ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis
biospace
April 10, 2018?AbbVie?(NYSE: ABBV), a research-based global biopharmaceutical company, today announced positive top-line results from the Phase 3 SELECT-COMPARE clinical trial -
Flare-responsive hydrogel developed to treat arthritis
europeanpharmaceuticalreview
April 09, 2018Researchers develop a better delivery system for anti-inflammatory therapies… -
Zimmer Biomet Announces Publication of Positive Results From PROGRESS II Trial of Autologous Protein
biospace
December 28, 2017Pilot Study Data Shows nSTRIDE APS Kit Provides Significantly Better Improvement in Pain from Baseline and Comparable Safety to Saline Control -
Arthritis: Act before it gets Late
biospectrumasia
September 14, 2017The theme for this year’s World Arthritis Day is ‘It’s in your hands, take action’. -
What do kids think of their parents' RA? Amgen's new Enbrel push offers a few ideas
fiercepharma
August 10, 2017Amgen has launched a new DTC campaign for arthritis drug Enbrel featuring children who have parents with the disease. -
Existing arthritis drug could save thousands in blood cancer treatment
pharmafile
August 04, 2017Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer treatment by tapping into the unexplored properties of methotrexate... -
EU recommendation for Sanofi and Regeneron's arthritis treatment
pharmafile
April 25, 2017Sanofi and Regeneron are celebrating the news that their treatment Kevzara (sarilumab) has received...
Pharma Sources Insight July 2025
